Through its support of scientific symposia, research grants, and collaborations, the Charles and Patricia Heidelberger Foundation remains steadfast in its mission to nurture the next generation of cancer researchers and contribute meaningfully to the global effort against cancer.

The Charles and Patricia Heidelberger Foundation for Cancer Research honors the scientific contributions of Professor Charles Heidelberger, a pioneering figure in cancer research, whose development of 5-fluorouracil (5-FU) remains a cornerstone in chemotherapy. His vision of collaborative research continues to drive the Foundation's efforts in fostering innovation and advancing the fight against cancer.